retatrutide type 2 diabetes phase 2 trial results 2024 π A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with diabetes, a new 3 shows. is part of an emerging generation Phase III retatrutide study demonstrates
Description
[PubMed: 26653408] [2] S
Weight loss products have strong consumer appeal but also possess characteristics of prescription drugs
And it is precisely here that new evidence is prompting caution
Sustainable results still depend on addressing underlying health factors alongside treatment
"Options with chicken are generally leaner than those with beef, so if you're keeping an eye on saturated fat, the chicken option may help," says Fiano
Our latest Health Service Report shows a fascinating disconnect
